Vivek N Ahya

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. doi request reprint Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation
    Vivek N Ahya
    Division of Pulmonary, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    J Heart Lung Transplant 30:175-81. 2011
  2. doi request reprint Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection
    Navkaranbir S Bajaj
    University of Alabama, Ryals School of Public Health, Birmingham, AL, USA
    Transpl Int 23:e26-31. 2010
  3. ncbi request reprint Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection
    Vivek N Ahya
    Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Heart Lung Transplant 26:839-44. 2007
  4. ncbi request reprint Noninfectious pulmonary complications after lung transplantation
    Vivek N Ahya
    Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Clin Chest Med 26:613-22, vi. 2005
  5. doi request reprint Lung transplant outcomes in white and African American recipients: special focus on acute and chronic rejection
    Rajiv Lingaraju
    Division of Pulmonary Critical Care, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Heart Lung Transplant 28:8-13. 2009
  6. doi request reprint Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in lung transplantation
    Bijan Ghassemieh
    Department of Medicine, University of Chicago Medical Center, Chicago, Illinois 60611, USA
    J Heart Lung Transplant 32:701-6. 2013
  7. doi request reprint Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases
    Brandon E Kremer
    Abramson Cancer Center, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    J Heart Lung Transplant 31:296-304. 2012
  8. ncbi request reprint Effects of lung allocation score on waiting list rankings and transplant procedures
    Rajiv Lingaraju
    Division of Pulmonary Critical Care, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Heart Lung Transplant 25:1167-70. 2006
  9. doi request reprint Risk factors for early primary graft dysfunction after lung transplantation: a registry study
    Catherine L Kuntz
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Clin Transplant 23:819-30. 2009
  10. pmc The effect of primary graft dysfunction on survival after lung transplantation
    Jason D Christie
    Division of Pulmonary, Allergy, and Critical Care Medicine, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 423 Guardian Drive, 719 Blockley Hall, Philadelphia, PA 19104, USA
    Am J Respir Crit Care Med 171:1312-6. 2005

Collaborators

Detail Information

Publications26

  1. doi request reprint Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation
    Vivek N Ahya
    Division of Pulmonary, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    J Heart Lung Transplant 30:175-81. 2011
    ..In this study, we found an increased risk of venous thromboembolism (VTE) in lung transplant recipients treated with a sirolimus (SIR)-based immunosuppressive regimen...
  2. doi request reprint Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection
    Navkaranbir S Bajaj
    University of Alabama, Ryals School of Public Health, Birmingham, AL, USA
    Transpl Int 23:e26-31. 2010
    ....
  3. ncbi request reprint Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection
    Vivek N Ahya
    Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Heart Lung Transplant 26:839-44. 2007
    ..We investigated the hypothesis that detection of latent Epstein-Barr virus (EBV) in peripheral blood may be a functional marker for the net effects of administered immunosuppression...
  4. ncbi request reprint Noninfectious pulmonary complications after lung transplantation
    Vivek N Ahya
    Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Clin Chest Med 26:613-22, vi. 2005
    ....
  5. doi request reprint Lung transplant outcomes in white and African American recipients: special focus on acute and chronic rejection
    Rajiv Lingaraju
    Division of Pulmonary Critical Care, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Heart Lung Transplant 28:8-13. 2009
    ....
  6. doi request reprint Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in lung transplantation
    Bijan Ghassemieh
    Department of Medicine, University of Chicago Medical Center, Chicago, Illinois 60611, USA
    J Heart Lung Transplant 32:701-6. 2013
    ..To better characterize this relationship of decreased incidence of CMV events with sirolimus, we examined known risk factors and characteristics of CMV events from the AIRSAC database...
  7. doi request reprint Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases
    Brandon E Kremer
    Abramson Cancer Center, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    J Heart Lung Transplant 31:296-304. 2012
    ..Post-transplant lymphoproliferative disorder (PTLD) is a complication of organ transplantation. The risk of developing PTLD varies depending on a number of factors, including the organ transplanted and the degree of immunosuppression used...
  8. ncbi request reprint Effects of lung allocation score on waiting list rankings and transplant procedures
    Rajiv Lingaraju
    Division of Pulmonary Critical Care, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Heart Lung Transplant 25:1167-70. 2006
    ....
  9. doi request reprint Risk factors for early primary graft dysfunction after lung transplantation: a registry study
    Catherine L Kuntz
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Clin Transplant 23:819-30. 2009
    ..We sought to identify risk factors for PGD using the United Network for Organ Sharing/International Society for Heart and Lung Transplant (UNOS/ISHLT) Registry...
  10. pmc The effect of primary graft dysfunction on survival after lung transplantation
    Jason D Christie
    Division of Pulmonary, Allergy, and Critical Care Medicine, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 423 Guardian Drive, 719 Blockley Hall, Philadelphia, PA 19104, USA
    Am J Respir Crit Care Med 171:1312-6. 2005
    ..Primary graft dysfunction is a severe acute lung injury syndrome after lung transplantation. Long-term outcomes of subjects with primary graft dysfunction have not been studied...
  11. doi request reprint Central airways obstruction due to Aspergillus fumigatus after lung transplantation
    Elizabeth Cerceo
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    J Heart Lung Transplant 28:515-9. 2009
    ..All 3 patients presented with atypical features of Aspergillus infection, but all responded to treatments with either steroids, anti-fungals or both...
  12. pmc Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis
    Michael W Sims
    Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Chest 140:489-96. 2011
    ..However, little is known about SP-D levels in the setting of lung transplantation...
  13. pmc Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis
    Adam Fang
    Division of Pulmonary, Allergy and Critical Care Medicine, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Chest 139:782-7. 2011
    ..The purpose of this study was to evaluate the relationship between mean pulmonary artery pressure (mPAP) and PGD among patients with IPF...
  14. pmc Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction
    Jason D Christie
    Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Am J Respir Crit Care Med 180:1010-5. 2009
    ..We hypothesized that patients with primary graft dysfunction (PGD) after lung transplantation would have higher RAGE levels in plasma than patients without PGD...
  15. ncbi request reprint Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder
    Donald E Tsai
    Hematologic Malignancies Program, University of Pennsylvania Cancer Center, Philadelphia, PA 19104, USA
    Clin Transplant 19:644-52. 2005
    ..68 wk, p = 0.003). Persistence of MG after complete response of the PTLD did not predict relapse. There is a high incidence of MG and gammaglobulin abnormalities in patients with PTLD...
  16. doi request reprint Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients
    Meghan Karuturi
    Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    Transpl Int 26:616-22. 2013
    ..Plasmacytic PTLD, despite its plasmacytic histology, is responsive to conventional therapies used for B-cell PTLD including reduction in immunosuppression and radiation therapy...
  17. ncbi request reprint Multiple variables affecting blood usage in lung transplantation
    Yongping Wang
    Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Heart Lung Transplant 25:533-8. 2006
    ..A few publications have reported on the role of variables affecting blood component usage during lung transplantation...
  18. ncbi request reprint Renal and vestibular toxicity due to inhaled tobramycin in a lung transplant recipient
    Vivek N Ahya
    Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Heart Lung Transplant 24:932-5. 2005
    ..We review the literature regarding the safety of inhaled tobramycin and discuss potential mechanisms that may promote systemic toxicity in transplant recipients...
  19. ncbi request reprint Surgical therapies for pulmonary arterial hypertension
    Jeffrey S Sager
    Lung Transplantation Program, Pulmonary, Allergy and Critical Care Division, University of Pennsylvania Medical Center, 828 West Gates Building, 3600 Spruce Street, Philadelphia, PA 19104, USA
    Clin Chest Med 28:187-202, ix. 2007
    ..This article discusses indications for and results of atrial septostomy and lung and heart-lung transplantation in patients who have pulmonary arterial hypertension...
  20. doi request reprint Conventional and novel approaches to immunosuppression
    Timothy Floreth
    Section of Pulmonary and Critical Care Medicine, Department of Medicine, University of Chicago Medical Center, Chicago, IL 60637, USA
    Clin Chest Med 32:265-77. 2011
    ..In this article, conventional immunosuppressive regimens, novel approaches to preventing graft rejection, and investigational agents for solid organ transplantation are reviewed...
  21. ncbi request reprint Hemodynamics and survival of patients with portopulmonary hypertension
    Steven M Kawut
    Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Liver Transpl 11:1107-11. 2005
    ..Future studies of the specific mechanisms of and therapy for pulmonary arterial hypertension should focus on the distinctions between the different forms of this disease...
  22. doi request reprint Lung transplantation in autoimmune diseases
    James C Lee
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Clin Chest Med 31:589-603. 2010
    ..The reasons for this low number are multifactorial. This article reviews issues relevant to all lung transplant candidates and recipients as well as those specific to patients with autoimmune diseases...
  23. ncbi request reprint Impact of primary graft failure on outcomes following lung transplantation
    Jason D Christie
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Chest 127:161-5. 2005
    ..Primary graft failure (PGF) is a severe acute lung injury syndrome that occurs following lung transplantation. We compared the clinical outcomes of patients who developed PGF with those who did not...
  24. ncbi request reprint Pulmonary complications of solid organ and hematopoietic stem cell transplantation
    Robert M Kotloff
    Section of Advanced Lung Disease and Lung Transplantation, Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania Medical Center, 838 West Gates, 3400 Spruce Street, Philadelphia, PA 19027, USA
    Am J Respir Crit Care Med 170:22-48. 2004
    ....
  25. doi request reprint Assessment of kidney function in lung transplant candidates
    Nadine Al-Naamani
    Lung Transplant Program, Columbia University, New York, New York 10032, USA
    J Heart Lung Transplant 27:635-41. 2008
    ..Although creatinine-based formulas that estimate GFR have been derived, none have been validated in patients with severe lung disease...
  26. ncbi request reprint Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: treatment
    Yaron Shargall
    Division of Thoracic Surgery, Toronto General Hospital, Toronto, Ontario, Canada
    J Heart Lung Transplant 24:1489-500. 2005